The Canadian Pharmacists Association has put together a resource preempting questions expectant mothers are likely to have about the common pain reliever.
Dr. Richard Frye told The Associated Press that he’d been talking with federal regulators about developing his own customized version of the drug for children with autism, assuming more research would be required.